Gene content    
FRAT1 ( by HUGO)
Frequently Rearranged In Advanced T-Cell Lymphomas
Oncogene & --
Frequently Rearranged In Advanced T-Cell Lymphomas
Frequently Rearranged In Advanced T-Cell Lymphomas 1
FRAT-1
Proto-Oncogene FRAT1
NCBI: 10q24.1    Ensembl: 10q24.1
FRAT1_HUMANSize: 279 amino acidsMass: 29093 Da

  • Subunit: Binds DVL1. Binds GSK-3 and prevent GSK-3-dependent phosphorylation 5 PDB 3D structures from [IMAGE] and Proteopedia [IMAGE] for FRAT1: 1GNG (3D) [IMAGE] 3ZRK (3D) [IMAGE] 3ZRL (3D) [IMAGE] 3ZRM (3D) [IMAGE] 4AFJ (3D) [IMAGE]
  • Function:
    UniProtKB/Swiss-Prot Summary: FRAT1_HUMAN, Q92837 Function: Positively regulates the Wnt signaling pathway by stabilizing beta-catenin through the association with GSK-3. May play a role in tumor progression and collaborate with PIM1 and MYC in lymphomagenesis Phenotypes: 1 GenomeRNAi human phenotype for FRAT1: Synthetic lethal with cisplati
  • Similarity:
    Belongs to the GSK-3-binding protein family [IMAGE]
  • Protein Domain/Family    
    Source ID Domain Name Type
    InterProIPR008014GSK3-bdGlycogen synthase kinase-3 binding proteinFamily
    BlocksIPB008014Glycogen synthase kinase-3 binding proteinGlycogen synthase kinase-3 binding protein

    Gene Ontology    
    Type Term Evidence Source Pub
    Biological Process Wnt receptor signaling pathway IEA GOA

    FRAT1 cross reference    
    PubMed OMIM Entrez Gene NCKU SNP Nucleotide UniProt Genome Data Viewer HomoloGene